- Name
- China Southern Hang Seng Biotech ETF(QDII)
- Index tracked
- Hang Seng Biotech PR
- Type
- Equity
- Management fee
- 0.5%
- Dividend policy
- Monthly
- NAV
- CNY 1.0289 (07/29/2026)
- Issued units
- 482.05M (07/29/2026)
- Listing date
- Jun 17, 2022
- Sponsor
- China Southern Fund Mgmt Co.,Ltd
- Custodian
- Agricultural Bank of China Ltd